NRXPW
NRX Pharmaceuticals, Inc.
Key Financials
Net Income
$-28622000
↓ 13.9%
Revenue
$1.2M
↑ Infinity%
Operating Income
$-16224000
↑ 12.3%
Shareholders' Equity
$-15937000.00
↑ 31.4%
Total Assets
$13.0M
↑ 254.9%
Cash & Equivalents
$7.8M
↑ 440.3%
EPS (Diluted)
$-0.60
↑ 69.7%
Total Liabilities
$28.9M
↑ 7.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| 8-K | 3/24/2026 | View on SEC |
| 10-K | 3/23/2026 | View on SEC |
| DEFA14A | 2/24/2026 | View on SEC |
| ARS | 2/23/2026 | View on SEC |
| DEF 14A | 2/23/2026 | View on SEC |
| 4 | 2/17/2026 | View on SEC |
| 3 | 2/17/2026 | View on SEC |
| 8-K | 2/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NRXPW |
| Company Name | NRX Pharmaceuticals, Inc. |
| CIK | 1719406 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 484-254-6134 |